vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $209.8M, roughly 1.7× MYRIAD GENETICS INC). On growth, APOGEE ENTERPRISES, INC. posted the faster year-over-year revenue change (1.6% vs -0.4%). Over the past eight quarters, APOGEE ENTERPRISES, INC.'s revenue compounded faster (2.9% CAGR vs 1.9%).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

APOG vs MYGN — Head-to-Head

Bigger by revenue
APOG
APOG
1.7× larger
APOG
$351.4M
$209.8M
MYGN
Growing faster (revenue YoY)
APOG
APOG
+2.0% gap
APOG
1.6%
-0.4%
MYGN
Faster 2-yr revenue CAGR
APOG
APOG
Annualised
APOG
2.9%
1.9%
MYGN

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
APOG
APOG
MYGN
MYGN
Revenue
$351.4M
$209.8M
Net Profit
$16.6M
Gross Margin
22.4%
70.0%
Operating Margin
7.3%
-2.7%
Net Margin
4.7%
Revenue YoY
1.6%
-0.4%
Net Profit YoY
568.8%
EPS (diluted)
$0.78
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
MYGN
MYGN
Q1 26
$351.4M
Q4 25
$348.6M
$209.8M
Q3 25
$358.2M
$205.7M
Q2 25
$346.6M
$213.1M
Q1 25
$345.7M
$195.9M
Q4 24
$341.3M
$210.6M
Q3 24
$342.4M
$213.3M
Q2 24
$331.5M
$211.5M
Net Profit
APOG
APOG
MYGN
MYGN
Q1 26
$16.6M
Q4 25
$16.5M
Q3 25
$23.6M
$-27.4M
Q2 25
$-2.7M
$-330.5M
Q1 25
$2.5M
$-100.0K
Q4 24
$21.0M
Q3 24
$30.6M
$-22.1M
Q2 24
$31.0M
$-36.7M
Gross Margin
APOG
APOG
MYGN
MYGN
Q1 26
22.4%
Q4 25
23.8%
70.0%
Q3 25
23.1%
69.9%
Q2 25
21.7%
71.2%
Q1 25
21.6%
68.5%
Q4 24
26.1%
71.7%
Q3 24
28.4%
70.2%
Q2 24
29.8%
69.6%
Operating Margin
APOG
APOG
MYGN
MYGN
Q1 26
7.3%
Q4 25
7.1%
-2.7%
Q3 25
7.5%
-11.3%
Q2 25
2.0%
-154.5%
Q1 25
1.8%
-14.8%
Q4 24
8.4%
-18.6%
Q3 24
12.3%
-9.4%
Q2 24
12.5%
-17.3%
Net Margin
APOG
APOG
MYGN
MYGN
Q1 26
4.7%
Q4 25
4.7%
Q3 25
6.6%
-13.3%
Q2 25
-0.8%
-155.1%
Q1 25
0.7%
-0.1%
Q4 24
6.1%
Q3 24
8.9%
-10.4%
Q2 24
9.4%
-17.4%
EPS (diluted)
APOG
APOG
MYGN
MYGN
Q1 26
$0.78
Q4 25
$0.77
$-0.09
Q3 25
$1.10
$-0.29
Q2 25
$-0.13
$-3.57
Q1 25
$0.12
$0.00
Q4 24
$0.96
$-0.47
Q3 24
$1.40
$-0.24
Q2 24
$1.41
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$39.5M
$149.6M
Total DebtLower is stronger
$232.3M
$119.9M
Stockholders' EquityBook value
$511.8M
$368.0M
Total Assets
$1.1B
$706.6M
Debt / EquityLower = less leverage
0.45×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
MYGN
MYGN
Q1 26
$39.5M
Q4 25
$41.3M
$149.6M
Q3 25
$39.5M
$145.4M
Q2 25
$32.8M
$74.4M
Q1 25
$41.4M
$91.8M
Q4 24
$43.9M
$102.4M
Q3 24
$51.0M
$99.9M
Q2 24
$30.4M
$97.3M
Total Debt
APOG
APOG
MYGN
MYGN
Q1 26
$232.3M
Q4 25
$119.9M
Q3 25
$119.5M
Q2 25
Q1 25
$285.0M
Q4 24
Q3 24
Q2 24
Stockholders' Equity
APOG
APOG
MYGN
MYGN
Q1 26
$511.8M
Q4 25
$512.3M
$368.0M
Q3 25
$500.2M
$372.8M
Q2 25
$481.8M
$388.1M
Q1 25
$487.9M
$704.9M
Q4 24
$522.1M
$701.1M
Q3 24
$506.4M
$731.7M
Q2 24
$480.0M
$740.5M
Total Assets
APOG
APOG
MYGN
MYGN
Q1 26
$1.1B
Q4 25
$1.1B
$706.6M
Q3 25
$1.2B
$728.1M
Q2 25
$1.2B
$677.3M
Q1 25
$1.2B
$1.0B
Q4 24
$1.2B
$1.0B
Q3 24
$917.1M
$1.1B
Q2 24
$889.0M
$1.1B
Debt / Equity
APOG
APOG
MYGN
MYGN
Q1 26
0.45×
Q4 25
0.33×
Q3 25
0.32×
Q2 25
Q1 25
0.58×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
MYGN
MYGN
Operating Cash FlowLast quarter
$122.5M
$10.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
7.37×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
MYGN
MYGN
Q1 26
$122.5M
Q4 25
$29.3M
$10.6M
Q3 25
$57.1M
$21.1M
Q2 25
$-19.8M
$-13.6M
Q1 25
$30.0M
$-16.3M
Q4 24
$31.0M
$6.6M
Q3 24
$58.7M
$700.0K
Q2 24
$5.5M
$2.6M
Free Cash Flow
APOG
APOG
MYGN
MYGN
Q1 26
Q4 25
$22.9M
Q3 25
$52.4M
Q2 25
$-26.9M
Q1 25
$19.1M
Q4 24
$22.0M
Q3 24
$50.2M
Q2 24
$-1.8M
FCF Margin
APOG
APOG
MYGN
MYGN
Q1 26
Q4 25
6.6%
Q3 25
14.6%
Q2 25
-7.8%
Q1 25
5.5%
Q4 24
6.4%
Q3 24
14.7%
Q2 24
-0.5%
Capex Intensity
APOG
APOG
MYGN
MYGN
Q1 26
7.8%
Q4 25
1.9%
Q3 25
1.3%
Q2 25
2.1%
Q1 25
3.2%
Q4 24
2.6%
Q3 24
2.5%
Q2 24
2.2%
Cash Conversion
APOG
APOG
MYGN
MYGN
Q1 26
7.37×
Q4 25
1.77×
Q3 25
2.41×
Q2 25
Q1 25
12.08×
Q4 24
1.48×
Q3 24
1.92×
Q2 24
0.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Architectural Services$127.1M36%
Architectural Metals$110.0M31%
Architectural Glass$67.4M19%
Performance Surfaces$54.3M15%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons